Skip to main content
. 2009 Sep 21;11(5):R71. doi: 10.1186/bcr2404

Figure 2.

Figure 2

Distribution of the LOH incidences in blood and primary tumor. Comparison of the loss of heterozygosity (LOH) frequencies detected at six different microsatellite markers (a) in blood serum samples from 81 breast cancer patients, and (b) in serum and tumor samples from 22 patients. The frequency of LOH was calculated by division of the number of LOH with the informative cases for each locus.